About us

About ANDHealth

Australia’s leading provider of accelerator, incubator and commercialisation programs for digital health technology companies.
Since 2017 ANDHealth has worked with over 400 digital health companies across Australia.

We have unique capabilities in technology identification, assessment and the design and delivery of programs proven to accelerate the commercialisation of digital health technologies and the scale-up of Australian digital health companies.

ANDHealth addresses a gap in the Australian Innovation landscape: to provide programs and commercial support to companies in the dynamic, emerging digital health sector.

Our unique non-profit industry-led model supports Australian digital health companies to navigate the commercialisation pathway from ideation to institutional investment and international market entry through highly specific programs and expert support, creating a growth sector which delivers highly skilled jobs, creates economic opportunity and delivers health outcomes for all Australians.

For ANDHealth’s latest annual report please click here

Corporate Members

Members & Partners
ANDHealth is a member owned public company limited by guarantee. Our Corporate Member network represents a unique multi-sectorial, multi-disciplinary group which works collaboratively to bring proven and demonstrable expertise to the companies we work with.

About Digital Health

Digital Health
Digital health is a fast-growing sector characterised by the use of digital technologies, either alone or in combination with physical products, to treat, diagnose, cure, mitigate and/or prevent disease or other conditions. It includes Health IT – but is not limited to it.

We subscribe to the US FDA’s definition of digital health,
which includes:
  • Mobile health (mHealth)
  • Health information technology (Health IT/e-health)
  • Connected and wearable devices
  • Telehealth and telemedicine
  • Personalised and precision medicine
Digital Medicines & Digital Therapeutics
Digital Health is a broad category that encompasses Digital Medicine, which in turn includes Digital Therapeutics.
Different levels of claims
Different levels of risk
Different evidence requirements.
Digital Medicine: high-quality hardware or software technologies as tools for measurement and intervention of human health.

Digital Therapeutics: high-quality software (may also include hardware) to deliver evidence-based therapeutic interventions that prevent, manage, or treat a health condition.

How we measure success

Our success is best demonstrated by the outcomes achieved by the companies we work with and the testimonials we receive from around Australia and the globe.

We have delivered over 1500 hours of tailored support to the Australian digital health sector since incorporating in March 2017 and our flagship incubator alumni companies have generated significant commercial outcomes.
Cohort Company Outcomes:
$31.6M
Raised (dilutive & non-dilutive)
$17.6M
New Revenue
217
New jobs (FTEs)
14
New CxO Roles
850
Commercial pilots commenced
38
Clinical trials and studies commenced
18
New international
market launches
171
New commercial customers
34
New patients served
326
New operational sites
46
New partnerships formed
120
New product releases
Testimonials
One of the key benefits of the ANDHealth+ program was that it was tailored to the needs of Vitalic Medical including our advisory panel. The advisory panel provided ongoing objective guidance on our business throughout the program helping to ensure we were focused in the right areas and on the right activities.
Sue Dafnias
CEO, Vitalic
The major difference I noted was the personalised nature to which the ANDHealth program is built. This ensured that we were not forced through standardised programs, expected to follow pre-ordained paths or work with professional generalists.
Charles Cornish
Executive Vice President, DoseMeRx (acquired by US-based Tabula Rasa HealthCare for up to AUD $40 million)
Digital health is an industry that often falls through the gaps between traditional software companies and biotech and the implications of this include lack of investor understanding, lack of commercialisation support and lack of industry expertise. ANDHealth goes a long way to solving these challenges by connecting digital health companies with leading stakeholders across all these groups and working to facilitate common understanding on how to work together.
Scott Taylor
CEO and Co-Founder, Perx Health
We have been part of numerous innovation communities including corporate incubators and VC-backed tech-accelerators. However, only ANDHealth+ has the deep expertise and commercial partnerships to truly understand a health-tech business and the unique hurdles they face to commercialise and find their path to market. Further, ANDHealth+ can be a trusted advisor with a clear mandate to help your business without competing interests.
Hugo Rourke
Co-Founder, Perx Health
ANDHealth provided Atmo with valuable digital health expertise and advice at a critical early-stage in the venture, which ultimately improved our ability to raise seed funding.
Malcom Hebblewhite
CEO, Atmo Biosciences
The ANDHealth team found the people and support we needed at the time we needed it. More than an accelerator, ANDHealth became an ongoing extension of my inner circle - a circle that helped me obtain a successful exit to a NASDAQ listed digital healthcare company.
Charles Cornish
Executive Vice President, DoseMeRx (acquired by US-based Tabula Rasa HealthCare for up to AUD $40 million)
The ANDHealth+ program was different to any other incubator and support we had received in the past. It was specific to the industry we were operating in - one that is particularly difficult to commercialise successfully in Australia - and our panel were experts. Blunt and honest in their feedback, they forced us to rethink our entire business model and value proposition.
Pete Saunders
Director, Health Delivered
The collective experience and resources brought by the program have enabled us to achieve pivotal milestones in commercialisation and clinical evidence generation and, as such, has enabled us to begin our global distribution, none of which would have been possible without our participation in the ANDHealth+ program.
Dr Raghav Murali-Ganesh
Co-Founder and President, CancerAid

Join our
mailing list

Stay up to date on news, programs and events
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.